Literature DB >> 27104

Human platelet MAO in drug-free and medicated schizophrenic patients.

A J Friedhoff, J C Miller, J Weisenfreund.   

Abstract

The authors compared platelet monoamine oxidase activity in drug-free chronic and acute schizophrenic patients, medicated chronic schizophrenic patients, and normal controls. A significant decrement in MAO activity was found only in medicated chronic schizophrenic patients. The possible mechanism for this finding is discussed.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 27104     DOI： 10.1176/ajp.135.8.952

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


  6 in total

Review 1.  Genetics and schizophrenic behavior.

Authors:  E Kahn
Journal:  Psychiatr Q       Date:  1980

2.  Platelet monoamine oxidase activity in first-degree relatives of schizophrenic patients.

Authors:  P Propping; W Friedl
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

3.  Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia.

Authors:  J Fang; P H Yu; J W Gorrod; A A Boulton
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

4.  Clinical variables and platelet mao in schizophrenia.

Authors:  I Sharma; A Kumar; J P Chansouria; S L Varma
Journal:  Indian J Psychiatry       Date:  1991-10       Impact factor: 1.759

5.  Platelet monoamine oxidase activity and schizophrenia--a myth that refuses to die?

Authors:  A Fleissner; R Seifert; K Schneider; W Eckert; B Fuisting
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

Review 6.  Human platelet monoamine oxidase activity in health and disease: a review.

Authors:  M Sandler; M A Reveley; V Glover
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.